1 asset in Septooptic Dysplasia
Therapeutic assets addressing Septooptic Dysplasia, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Setmelanotide Septooptic Dysplasia | Rhythm Pharmaceuticals, Inc. | P3 | B (60) |